rs140662042
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2
The NM_000292.3(PHKA2):c.718-3C>T variant causes a splice region, splice polypyrimidine tract, intron change. The variant allele was found at a frequency of 0.0151 in 1,157,524 control chromosomes in the GnomAD database, including 121 homozygotes. There are 4,958 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_000292.3 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PHKA2 | NM_000292.3 | c.718-3C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000379942.5 | NP_000283.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PHKA2 | ENST00000379942.5 | c.718-3C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_000292.3 | ENSP00000369274 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0114 AC: 1285AN: 113202Hom.: 8 Cov.: 23 AF XY: 0.00996 AC XY: 352AN XY: 35350
GnomAD3 exomes AF: 0.0101 AC: 1845AN: 183016Hom.: 11 AF XY: 0.00984 AC XY: 665AN XY: 67550
GnomAD4 exome AF: 0.0155 AC: 16220AN: 1044270Hom.: 113 Cov.: 24 AF XY: 0.0144 AC XY: 4606AN XY: 320118
GnomAD4 genome AF: 0.0113 AC: 1284AN: 113254Hom.: 8 Cov.: 23 AF XY: 0.00994 AC XY: 352AN XY: 35412
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 23, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Glycogen storage disease IXa1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 20, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 09, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at